Related Experiment Video
Updated: May 14, 2026

07:38
Strategies for Assessing Autistic-Like Behaviors in Mice
Published on: September 20, 2024
Behavioural and functional characterization of Kv10.1 (Eag1) knockout mice
Roser Ufartes1, Tomasz Schneider, Lena Sünke Mortensen
1Department of Molecular Biology of Neuronal Signals, Max-Planck-Institute for Experimental Medicine, Hermann-Rein-Str. 3, Göttingen 37077, Germany. rufarte@gwdg.de
Human Molecular Genetics
|February 21, 2013
Summary
The voltage-gated potassium channel Kv10.1 (Eag1) knockout mice showed no significant brain abnormalities or behavioral deficits. This lack of phenotype supports Kv10.1 targeting for cancer therapy.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Kv10.1 (Eag1) is a voltage-gated potassium channel predominantly expressed in the adult brain.
- Kv10.1's role in brain function is not fully understood, despite its overexpression in numerous human cancers.
Purpose of the Study:
- To investigate the functional significance of Kv10.1 in the brain.
- To generate and characterize Kv10.1-deficient mice to assess its in vivo neurological and behavioral roles.
Main Methods:
- Utilized a '3 Lox P strategy' to delete exon 7 of the KCNH1 gene, creating non-functional Kv10.1 proteins.
- Conducted comprehensive assessments including anatomical analysis, general health screening, sensorimotor function tests, and behavioral evaluations (anxiety, social behavior, learning, memory).
- Performed electrophysiological recordings in cerebellar Purkinje cells and assessed responses to various pharmacological agents.
Main Results:
- Kv10.1-deficient mice exhibited normal embryogenesis, development, and anatomy of major brain regions (cortex, hippocampus, cerebellum).
- No significant functional aberrations were observed in sensorimotor gating, anxiety, social behavior, learning, or memory.
- Mild hyperactivity and prolonged haloperidol-induced catalepsy were noted, but no genotype differences were found in responses to amphetamine, apomorphine, or antidepressants.
Conclusions:
- The absence of a marked phenotype in Kv10.1 knockout mice suggests limited essential roles in normal brain development and function.
- These findings provide a crucial foundation for exploring Kv10.1 inhibition strategies, such as siRNA, for cancer treatment, given its tumor overexpression.
- The study validates Kv10.1 as a potential therapeutic target in oncology without apparent detrimental effects on neurological function.

